Recent Progress in Health Benefits of Hederagenin and Its Glycosides
Molecules · 15.08.2025 · 30 (16) · 3393
DOI: 10.3390/molecules30163393 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 15.08.2025. Verfasst von Guangjie Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Biology and Food Engineering, Anyang Institute of Technology, Anyang 455000, China. Hauptthemen laut MEDLINE: Oleanolic Acid, Glycosides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Scientific Research Fund for Doctoral Start-up Project of Anyang Institute of Technology, Key R & D Project of Henan Province, Laboratory of Xinjiang Native Medicinal and Edible Plant Resources Chemistry, Kashi University.
Abstract (Originalsprache)
Hederagenin, a pentacyclic triterpenoid saponin from various medicinal plants, shows immense therapeutic potential; however, its inherent low bioavailability severely hinders its clinical translation. This comprehensive review synthesizes recent studies on the health benefits of hederagenin and its glycosides, critically the chemical modification strategies and pharmacological mechanisms aimed at optimizing its bioactivity. Key findings reveal that its broad anticancer and anti-inflammatory activities largely stem from its capacity to modulate crucial cellular signaling pathways, including the NF-κB, PI3K/Akt, and MAPK. Structural modification, particularly intelligent derivatization at the C-28 position, is a central strategy to overcome its pharmacokinetic deficiencies and significantly boost cytotoxicity. Furthermore, its unique pro-oxidant function within cancer cells, achieved by inhibiting the Nrf2-ARE antioxidant pathway, offers a novel approach for selective chemotherapeutics. For the clinical translation of hederagenin, we propose a strategic focus on derivatization through multi-target hybrids and sophisticated delivery systems. This approach is essential for addressing its pharmacokinetic barriers while strategically leveraging its context-dependent pro-oxidant effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biology and Food Engineering, Anyang Institute of Technology, Anyang 455000, China.
- School of Food Science and Engineering, Yangzhou University, Yangzhou 225127, China.
- College of Food Science and Engineering, Jilin University, Changchun 130062, China.
ORCID-Profile: Yining Feng, Jie Zhang, Tianzhu Guan
Förderung
- the Scientific Research Fund for Doctoral Start-up Project of Anyang Institute of Technology
- Key R & D Project of Henan Province
- Laboratory of Xinjiang Native Medicinal and Edible Plant Resources Chemistry, Kashi University
- Postgraduate Research & Practice Innovation Program of Jiangsu Province
- Scientific Research Fund for Doctoral Start-up Project of Anyang Institute of Technology
- Key R & D Project of Henan Province
- Postgraduate Research & Practice Innovation Program of Jiangsu Province
Zitieren
APA
Zhang, G., Feng, Y., Huang, L., Ren, C., Gao, M., Zhang, J., & Guan, T. (2025). Recent Progress in Health Benefits of Hederagenin and Its Glycosides. Molecules, 30(16), 3393. https://doi.org/10.3390/molecules30163393
Vancouver
Zhang G, Feng Y, Huang L, Ren C, Gao M, Zhang J, et al. Recent Progress in Health Benefits of Hederagenin and Its Glycosides. Molecules. 2025;30(16):3393. doi:10.3390/molecules30163393
BibTeX
@article{Zhang2025,
author = {Zhang, Guangjie and Feng, Yining and Huang, Li and Ren, Chenxi and Gao, Mingyuan and Zhang, Jie and Guan, Tianzhu},
title = {Recent Progress in Health Benefits of Hederagenin and Its Glycosides},
journal = {Molecules},
year = {2025},
volume = {30},
number = {16},
pages = {3393},
doi = {10.3390/molecules30163393}
}
EUVIMED